article thumbnail

D.C. Circuit Sides with Manufacturers in Latest 340B Contract Pharmacy Case

FDA Law Blog

Kirschenbaum — Last week, the United States Court of Appeals for the District of Columbia ruled that Section 340B of the Public Health Service Act does not prohibit pharmaceutical manufacturers from imposing conditions on the distribution of discounted drugs to covered entities in the program. In United Therapeutics Corporation v.

article thumbnail

Germany court rejects climate lawsuit in favor of Mercedes-Benz

JURIST

Deutsche Umwelthilfe Federal Managing Director stated that the “new vehicles from Mercedes have the highest CO2 emissions of all manufacturers in Europe” and “the German car manufacturers have been preventing effective climate protection laws for decades.”

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

California legislature introduces legislation authorizing private citizen suits against gun industry

JURIST

The California legislature proposed Assembly Bill 1594 (AB1594) Monday authorizing private citizens harmed by illegal gun use to sue manufacturers, distributors and sellers of firearms.

article thumbnail

Canada Federal Court declares cabinet order enabling ban of single-use plastics unconstitutional

JURIST

The Federal Court of Canada delivered a decision on Thursday overturning the federal government’s order to list plastic-manufactured items (PMIs) under Schedule 1 of the Canadian Environmental Protection Act 1999 (CEPA).

Court 232
article thumbnail

South Korea Supreme Court orders Japan companies to compensate former victims of forced labor

JURIST

The Supreme Court of Korea found on Thursday that shipbuilder Hitachi Zosen Corp. and heavy equipment manufacturer Mitsubishi Heavy Industries owe 50 million won (approx. The court’s Thursday ruling upheld two lower court decisions. The same court then found the same for Mitsubishi Heavy in June 2019.

Court 130
article thumbnail

The Fourth Circuit Upholds CMS’ Definition of “Line-Extension Drug” and “New Formulation”

FDA Law Blog

Gaulkin — On April 10, the Fourth Circuit unanimously affirmed a summary judgment ruling for the Centers for Medicare & Medicaid Services (CMS) regarding the agency’s definitions of “line-extension drug” and “new formulation” for purposes of determining rebates that drug manufacturers may owe the Medicaid Drug Rebate Program (MDRP).

article thumbnail

United States: Eleventh Circuit Holds FLSA Administrative Exemption Applies To Business Development Managers Who Drove Business To Car Manufacturer - Littler Mendelson

Mondaq

Court of Appeals for the Eleventh Circuit, in Brown v. Nexus Business Solutions, LLC affirmed a district court's decision that business development managers who solicited and sold General Motors. On April 1, 2022, the U.S.